BioSig Technologies Inc (OTCMKTS:BSGM) Director Patrick Joseph Gallagher bought 20,000 shares of the business’s stock in a transaction on Friday, March 9th. The stock was purchased at an average price of $1.40 per share, for a total transaction of $28,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Shares of OTCMKTS:BSGM opened at $2.17 on Friday. The firm has a market cap of $57.12, a P/E ratio of -3.62 and a beta of 0.51. BioSig Technologies Inc has a 12 month low of $1.23 and a 12 month high of $2.36.
Separately, Zacks Investment Research lowered shares of BioSig Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, January 2nd.
TRADEMARK VIOLATION WARNING: This piece was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/07/biosig-technologies-inc-bsgm-director-patrick-joseph-gallagher-buys-20000-shares.html.
BioSig Technologies Company Profile
BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.